Credential Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

Credential Securities’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$240K	Buy	696 +51	+8%	+$15.9K	0.05%	155
2018 Q1	$222K	Buy	645 +67	+12%	+$23.3K	0.05%	162
2017 Q4	$217K	Buy	578 +244	+73%	+$98.8K	0.05%	164
2017 Q3	$149K	Sell	334 -9	-3%	-$4.28K	0.04%	179
2017 Q2	$175K	Sell	343 -55	-14%	-$24.1K	0.05%	178
2017 Q1	$154K	Buy	398 +2	+0.5%	+$741	0.05%	173
2016 Q4	$145K	Buy	+396	New	+$151K	0.06%	171

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Credential Securities's REGN Position: Q2 2018 in Review

Credential Securities increased its Regeneron Pharmaceuticals (REGN) stake by 7.9% in Q2 2018, buying an estimated $15.9K and bringing the position to 696 shares worth $240K. The position accounts for 0.05% of the portfolio, ranked #155.

Credential Securities first reported a position in REGN in Q4 2016 and has held it in 7 quarters since. 625 funds tracked by Wall St. Rank hold REGN as of Q2 2018.

Credential Securities held 696 shares of Regeneron Pharmaceuticals worth $240K as of Q2 2018.
Credential Securities bought 51 Regeneron Pharmaceuticals shares in Q2 2018, an estimated $15.9K.
Regeneron Pharmaceuticals made up 0.05% of Credential Securities's portfolio in Q2 2018, its #155 holding.
Credential Securities first reported a position in Regeneron Pharmaceuticals in Q4 2016 and has held it in 7 quarters since.
625 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2018.

Based on Credential Securities's 13F filing for Q2 2018, filed 21 Jul 2025.